日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Persephonella marina 50S ribosomal protein L2 (rplB) CSB-YP507899EUA
CSB-EP507899EUA
CSB-BP507899EUA
CSB-MP507899EUA
CSB-EP507899EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina 30S ribosomal protein S8 (rpsH) CSB-YP507900EUA
CSB-EP507900EUA
CSB-BP507900EUA
CSB-MP507900EUA
CSB-EP507900EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP507901EUA
CSB-EP507901EUA
CSB-BP507901EUA
CSB-MP507901EUA
CSB-EP507901EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina Probable septum site-determining protein MinC (minC) CSB-YP507902EUA
CSB-EP507902EUA
CSB-BP507902EUA
CSB-MP507902EUA
CSB-EP507902EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP507903EUA
CSB-EP507903EUA
CSB-BP507903EUA
CSB-MP507903EUA
CSB-EP507903EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina Probable endonuclease 4 (nfo) CSB-YP507904EUA
CSB-EP507904EUA
CSB-BP507904EUA
CSB-MP507904EUA
CSB-EP507904EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina DNA ligase (ligA), partial CSB-YP507905EUA
CSB-EP507905EUA
CSB-BP507905EUA
CSB-MP507905EUA
CSB-EP507905EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina Sulfate adenylyltransferase (sat) CSB-YP507906EUA
CSB-EP507906EUA
CSB-BP507906EUA
CSB-MP507906EUA
CSB-EP507906EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina 50S ribosomal protein L21 (rplU) CSB-YP507907EUA
CSB-EP507907EUA
CSB-BP507907EUA
CSB-MP507907EUA
CSB-EP507907EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina 50S ribosomal protein L20 (rplT) CSB-YP507908EUA
CSB-EP507908EUA
CSB-BP507908EUA
CSB-MP507908EUA
CSB-EP507908EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina Ketol-acid reductoisomerase (ilvC) CSB-YP507909EUA
CSB-EP507909EUA
CSB-BP507909EUA
CSB-MP507909EUA
CSB-EP507909EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina 30S ribosomal protein S15 (rpsO) CSB-YP507910EUA
CSB-EP507910EUA
CSB-BP507910EUA
CSB-MP507910EUA
CSB-EP507910EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina 50S ribosomal protein L19 (rplS) CSB-YP507911EUA
CSB-EP507911EUA
CSB-BP507911EUA
CSB-MP507911EUA
CSB-EP507911EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina Pyridoxine 5'-phosphate synthase (pdxJ) CSB-YP507912EUA
CSB-EP507912EUA
CSB-BP507912EUA
CSB-MP507912EUA
CSB-EP507912EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit B CSB-YP507913EUA
CSB-EP507913EUA
CSB-BP507913EUA
CSB-MP507913EUA
CSB-EP507913EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Persephonella marina SsrA-binding protein (smpB) CSB-YP507914EUA
CSB-EP507914EUA
CSB-BP507914EUA
CSB-MP507914EUA
CSB-EP507914EUA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brachyspira hyodysenteriae 50S ribosomal protein L5 (rplE) CSB-YP507915BVT
CSB-EP507915BVT
CSB-BP507915BVT
CSB-MP507915BVT
CSB-EP507915BVT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brachyspira hyodysenteriae Elongation factor P (efp) CSB-YP507916BVT
CSB-EP507916BVT
CSB-BP507916BVT
CSB-MP507916BVT
CSB-EP507916BVT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brachyspira hyodysenteriae Leucine--tRNA ligase (leuS), partial CSB-YP507917BVT
CSB-EP507917BVT
CSB-BP507917BVT
CSB-MP507917BVT
CSB-EP507917BVT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brachyspira hyodysenteriae Formate--tetrahydrofolate ligase (fhs), partial CSB-YP507918BVT
CSB-EP507918BVT
CSB-BP507918BVT
CSB-MP507918BVT
CSB-EP507918BVT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×